Celanese Corp. (CE) News
Filter CE News Items
CE News Results
|Loading, please wait...|
CE News Highlights
- CE's 30 day story count now stands at 10.
- Over the past 19 days, the trend for CE's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about CE are API, DRUG and ED.
Latest CE News From Around the Web
Below are the latest news stories about CELANESE CORP that investors may wish to consider to help them evaluate CE as an investment opportunity.
Facing an ambiguous market environment that could go either way, investors should turn to undervalued Warren Buffett stocks to buy.
Given their performance in August, there are several undervalued materials stocks to buy from the S&P 500 in September.
The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.
DALLAS, September 12, 2023--Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
When the most successful investor of all time unloads Warren Buffet stocks, investors would be wise to pay close attention.
Oracle upgraded, Farfetch downgraded: Wall Street's top analyst calls
Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at VMware, Celanese, Upwork, and Farfetch. Monness, Crespi, Hardt downgraded VMware (NYSE:VMW) to Neutral from Buy ahead of the company’s Q2/24 earnings on Thursday. The firm highlighted VMware's stock performance during the 2022 tech decline and its continued growth this year, citing "a modest valuation for a software stock, a unique value proposition in the cloud, an attractive margin profile," and support from the pending deal with Broadcom (NASDAQ:AVGO).
Uncovering the Risks and Rewards of Investing in Celanese Corp (CE)